Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 37
2022 44
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Oxford-AstraZeneca COVID-19 vaccine efficacy.
Knoll MD, Wonodi C. Knoll MD, et al. Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. Epub 2020 Dec 8. Lancet. 2021. PMID: 33306990 Free PMC article. No abstract available.
Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
Sønderskov KM, Dinesen PT, Østergaard SD. Sønderskov KM, et al. Dan Med J. 2021 Mar 31;68(5):A03210292. Dan Med J. 2021. PMID: 33870886 Free article.
RESULTS We found sustained vaccine willingness after the reported cases of thromboembolic events (89% both before and after). However, the safety of the Oxford-AstraZeneca COVID-19 vaccine was perceived to be significantly and substantially lowe …
RESULTS We found sustained vaccine willingness after the reported cases of thromboembolic events (89% both before and after). However, the s …
COVID-19 Vaccine-Induced Thrombotic Thrombocytopaenia With Venous and Arterial Thrombosis: A Case Report.
Khan Z, Besis G, Candilio L. Khan Z, et al. Cureus. 2022 Aug 29;14(8):e28535. doi: 10.7759/cureus.28535. eCollection 2022 Aug. Cureus. 2022. PMID: 36185940 Free PMC article.
It was however reported that COVID-19 vaccines in particular, the Oxford-AstraZeneca COVID-19 vaccine (AZD1222) was temporarily suspended by some European countries due to risk of thrombosis. ...
It was however reported that COVID-19 vaccines in particular, the Oxford-AstraZeneca COVID-19 vaccine (AZ …
COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia.
Solomon Y, Eshete T, Mekasha B, Assefa W. Solomon Y, et al. J Multidiscip Healthc. 2021 Sep 16;14:2577-2585. doi: 10.2147/JMDH.S331140. eCollection 2021. J Multidiscip Healthc. 2021. PMID: 34556992 Free PMC article.
So, this study assessed the immediate symptoms associated with taking the Oxford-AstraZeneca COVID-19 vaccine. METHODS: This online study was conducted from April 15 to 30, 2021 at a national level across health care providers who took their fir …
So, this study assessed the immediate symptoms associated with taking the Oxford-AstraZeneca COVID-19 vaccine …
Immunogenicity of Oxford-AstraZeneca COVID-19 Vaccine in Vietnamese Health-Care Workers.
Chau NVV, Nguyet LA, Truong NT, Toan LM, Dung NT, Hung LM, Nhan MT, Man DNH, Ngoc NM, Thao HP, Tu TNH, Mai HK, Hung DT, Ny NTH, Thanh LK, Anh NT, Hong NTT, Nhu LNT, Yen LM, Choisy M, Thanh TT, Thwaites G, Tan LV; Oxford University Clinical Research Unit COVID-19 Research Group. Chau NVV, et al. Am J Trop Med Hyg. 2022 Jan 7;106(2):556-561. doi: 10.4269/ajtmh.21-0849. Am J Trop Med Hyg. 2022. PMID: 34996048 Free PMC article.
At month 3, neutralizing antibodies decreased and 94.7% (89 of 94) of the study participants remained seropositive. The Oxford-AstraZeneca COVID-19 vaccine is immunogenic in Vietnamese health-care workers. ...
At month 3, neutralizing antibodies decreased and 94.7% (89 of 94) of the study participants remained seropositive. The Oxford-Ast …
Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches.
Marei HE, Althani A, Afifi N, Pozzoli G, Caceci T, Angelini F, Cenciarelli C. Marei HE, et al. Mol Biol Rep. 2021 Sep;48(9):6513-6524. doi: 10.1007/s11033-021-06630-4. Epub 2021 Aug 16. Mol Biol Rep. 2021. PMID: 34398427 Free PMC article. Review.
The current vaccination campaign is ongoing worldwide using different types of vaccines such as Pfizer-BioNTech and Moderna, Johnson & Johnson, Oxford-AstraZeneca, Novavax, and others with efficacy ranging from 72-95%. In March 2021 Germany limited the use of the Oxford …
The current vaccination campaign is ongoing worldwide using different types of vaccines such as Pfizer-BioNTech and Moderna, Johnson & J …
97 results